Teva Pharmaceuticals
TEVA
TEVA
425 hedge funds and large institutions have $3.73B invested in Teva Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 130 increasing their positions, 137 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
425
Holders Change
-11
Holders Change %
-2.52%
% of All Funds
6.7%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.21%
New
50
Increased
130
Reduced
137
Closed
60
Calls
$162M
Puts
$145M
Net Calls
+$16.5M
Net Calls Change
+$50.3M
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
$141M |
| 2 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
$238M |
| 3 |
SPC
Slate Path Capital
New York
|
$93.7M |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
$254M |
| 5 |
Norges Bank
Oslo,
Norway
|
$83.9M |
